quinazolines has been researched along with Pre-Eclampsia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mishra, N; Nugent, WH; Strauss, JF; Walsh, SW | 1 |
Bates, DO; Bills, VL; Harper, SJ; Jeffery, B; Neal, CR; Overton, TG; Salmon, AH; Soothill, PW | 1 |
Duffy, GJ; Martin, F; O'Dwyer, WF | 1 |
1 trial(s) available for quinazolines and Pre-Eclampsia
Article | Year |
---|---|
The effects of a new diuretic (metolazone) on pre-eclamptic toxaemia of pregnancy.
Topics: Administration, Oral; Adult; Diuretics; Evaluation Studies as Topic; Female; Humans; Pre-Eclampsia; Pregnancy; Quinazolines; Sulfonamides | 1972 |
2 other study(ies) available for quinazolines and Pre-Eclampsia
Article | Year |
---|---|
Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1.
Topics: Adult; Angiotensin II; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Matrix Metalloproteinase 1; Omentum; Organ Culture Techniques; Pre-Eclampsia; Pregnancy; Pyrroles; Quinazolines; Receptor, PAR-1; Vasoconstriction; Young Adult | 2016 |
Impaired vascular permeability regulation caused by the VEGF₁₆₅b splice variant in pre-eclampsia.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Biological Assay; Capillary Permeability; Female; Humans; Membrane Proteins; Pre-Eclampsia; Pregnancy; Quinazolines; Ranidae; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2011 |